Integration of genetic colocalizations with physiological and pharmacological perturbations identifies cardiometabolic disease genes
Michael J. Gloudemans, Ivan Carcamo‐Orive(Ikerbasque), Joshua W. Knowles(Cardiovascular Institute of the South), Brunilda Balliu(Ben-Gurion University of the Negev), Thomas Quertermous(Amgen (United States)), Daniel Nachun(Stanford University), Matthew G. Durrant(Palo Alto Institute), Theresia M. Schnurr(Cardiovascular Institute of the South), Stephen B. Montgomery(Stanford University), Martin Wabitsch(Universität Ulm), Erik Ingelsson(Wave Life Sciences (United States))
Cited by 23
Related Papers
Exploring the phenotypic consequences of tissue specific gene expression variation inferred from GWAS summary statistics
|Nature Communications|2018|1.2k
Genome-wide meta-analyses identify multiple loci associated with smoking behavior
|Nature Genetics|2010|1.2k
RNA Sequencing and Analysis
|Cold Spring Harbor Protocols|2015|925